Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
The ALRCaN Global webinar, “Germline Predisposition and Acute Leukemia,” is scheduled for Friday, August 14, 2026, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). Presented by Anna Avagyan and organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of the network’s weekly educational series featuring […]
